Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors during the central anxious process, conolidine modulates alternate molecular targets. A Science Innovations research observed that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability... https://proleviate-conolidine-ben53729.blogsumer.com/36947414/5-simple-statements-about-conolidin-to-replace-traditional-painkillers-explained